Joshua E. Palmer

Dr. Palmer has presented and published on psychiatric topics across the lifespan including screening for adolescent vaping use, adolescent substance use, opioid use disorder treatments, neurobiological perspectives of mental illness, and methods to reduce medication use for behavioral disturbances in dementia. Today, he continues to evaluate the impact of the COVID-19 pandemic on the treatment delivery of psychiatric and substance use treatment.  

Clinically, Dr. Palmer currently practices as a psychiatric mental health nurse practitioner at P.K. Mullick and Associates, treating adult patients for general psychiatric conditions, substance use disorders, and severe persistent mental illness such as schizophrenia. Currently, Dr. Palmer’s clinical interest is using esketamine for treatment resistant depression.

In the past 15 years, Dr. Palmer has worked with individuals suffering from severe mental illness as a case manager, a service coordinator, and a psychiatric nurse. As a practicing nurse, Dr. Palmer worked as an Assertive Community Treatment (ACT) nurse case manager who provided medical case management, outreach, and psychiatric treatment for individuals with serious persistent mental illness who have demonstrated a high service need such as multiple hospitalization, ER visits, or difficulty in maintaining stability in the community.

Dr. Palmer initially earned a Bachelor of Science (BS) degree with a focus on psychology in 2003. He completed the Bachelor of Science in Nursing (BSN) program in 2017 and completed the Doctor of Nursing Practice (DNP) program in 2020, all at the University of Pittsburgh. Dr. Palmer’s DNP project involved using research to evaluate effectiveness and outcomes of a buprenorphine (Suboxone) practice and made recommendations to improve the quality of care.